Patents by Inventor Andreas Scheidig
Andreas Scheidig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230416702Abstract: The present invention relates to a synthetic phytase which is a shuffling product comprising biobricks of at least two reference phytases of Obesumbacterium and/or Hafnia.Type: ApplicationFiled: November 17, 2021Publication date: December 28, 2023Inventors: Andreas MICHELS, Andreas SCHEIDIG, Thomas HORN, Alexander METTEN
-
Publication number: 20230092791Abstract: The present invention relates to a protease variant which is at least 90% identical to the full length amino acid sequence of a Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3, while maintaining proteolytic activity, or a fragment, fraction or shuffled variant thereof maintaining proteolytic activity, which protease variant demonstrates altered or improved stability compared to the Kumamolisin AS wildtype as set forth in SEQ ID NO 4, or the Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3.Type: ApplicationFiled: June 27, 2022Publication date: March 23, 2023Inventors: Andreas Michels, Andreas Scheidig, Christian Elend, Claudia Krapp, Thomas Horn
-
Patent number: 11396648Abstract: The present invention relates to a protease variant which is at least 90% identical to the full length amino acid sequence of a Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3, while maintaining proteolytic activity, or a fragment, fraction or shuffled variant thereof maintaining proteolytic activity, which protease variant demonstrates altered or improved stability compared to the Kumamolisin AS wildtype as set forth in SEQ ID NO 4, or the Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3.Type: GrantFiled: December 22, 2017Date of Patent: July 26, 2022Assignee: EW NUTRITION GMBHInventors: Andreas Michels, Andreas Scheidig, Christian Elend, Claudia Krapp, Thomas Horn
-
Publication number: 20220108561Abstract: A system and a method for capturing a movement pattern of a person. The method comprises capturing a plurality of images of the person executing a movement pattern by means of a non-contact sensor, the plurality of images representing the movements of the body elements of the person, generating at least one skeleton model having limb positions for at least some of the plurality of images, and calculating the movement pattern from the movements of the body elements of the person by comparing changes in the limb positions in the at least one skeleton model generated.Type: ApplicationFiled: January 7, 2020Publication date: April 7, 2022Inventors: Horst-Michael Groß, Andrea Scheidig, Thanh Quang Trinh, Benjamin Schütz, Alexander Vorndran, Andreas Bley, Anke Mayfarth, Robert Arenknecht, Johannes Trabert, Christian Martin, Christian Sternitzke
-
Publication number: 20190322994Abstract: The present invention relates to a protease variant which is at least 90% identical to the full length amino acid sequence of a Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3, while maintaining proteolytic activity, or a fragment, fraction or shuffled variant thereof maintaining proteolytic activity, which protease variant demonstrates altered or improved stability compared to the Kumamolisin AS wildtype as set forth in SEQ ID NO 4, or the Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3.Type: ApplicationFiled: December 22, 2017Publication date: October 24, 2019Inventors: Andreas Michels, Andreas Scheidig, Christian Elend, Claudia Krapp, Thomas Horn
-
Publication number: 20190230958Abstract: The present invention relates to a feed composition comprising an acid protease.Type: ApplicationFiled: June 23, 2017Publication date: August 1, 2019Inventors: Andreas MICHELS, Andreas SCHEIDIG, Ronny MARTINEZ-MOYA, Diana WEBER
-
Patent number: 9534046Abstract: Provided herein are antibodies, antigen binding portions, and derivatives thereof that are capable of binding tumor necrosis factor alpha (TNF?); nucleic acids encoding the antibodies, antigen binding portions, and derivatives thereof, including complementary nucleic acids; vectors; and host cells containing the nucleic acids.Type: GrantFiled: April 24, 2015Date of Patent: January 3, 2017Assignee: BAYER INTELLECTUAL PROPERTY GMBHInventors: Christian Votsmeier, Uwe Gritzan, Kornelia Kirchner, Michael Strerath, Kerstin Baral, Ulrich Haupts, Wayne M. Coco, Susanne Steinig, Andreas Scheidig, Klaus Pellengahr, Simone Brückner, Hanna Plittersdorf, Peter Scholz, Jan Tebbe
-
Publication number: 20160130627Abstract: The technology disclosed herein relates to novel methods and compositions for the production processes of algae cell components from algae of the genus Haematococcus. The extractability of algae cellular components is improved and the process is optimized and accelerated by using the enzyme compositions according to the present invention.Type: ApplicationFiled: January 2, 2012Publication date: May 12, 2016Applicant: DIREVO Industrial Biotechnology GmbHInventors: Klaudija Milos, Claudia Stamme, Tanja Lindner, Vitaly Svetlichny, Andreas Scheidig
-
Publication number: 20150329629Abstract: Provided herein are antibodies, antigen binding portions, and derivatives thereof that are capable of binding tumor necrosis factor alpha (TNF?); nucleic acids encoding the antibodies, antigen binding portions, and derivatives thereof, including complementary nucleic acids; vectors; and host cells containing the nucleic acids.Type: ApplicationFiled: April 24, 2015Publication date: November 19, 2015Inventors: Christian Votsmeier, Uwe Gritzan, Kornelia Kirchner, Michael Strerath, Kerstin Baral, Ulrich Haupts, Wayne M. Coco, Susanne Steinig, Andreas Scheidig, Klaus Pellengahr, Simone Brückner, Hanna Plittersdorf, Peter Scholz, Jan Tebbe
-
Publication number: 20140045217Abstract: The present disclosure provides novel methods and compositions for improved production processes of algae cell components. In particular the present disclosure relates to methods for improving the extractability of algae cellular compositions.Type: ApplicationFiled: January 2, 2012Publication date: February 13, 2014Applicant: DIREVO INDUSTRIAL BIOTECHNOLOGY GMBHInventors: Klaudija Milos, Claudia Stamme, Tanja Lindner, Vitaly Svetlichny, Andreas Scheidig
-
Publication number: 20130344576Abstract: The technology disclosed herein relates to novel methods and compositions for the production processes of algae cell components from algae of the genus Scenedesmus. The extractability of algae cellular components is improved and the process is optimized and accelerated by using the enzyme compositions according to the present invention.Type: ApplicationFiled: January 2, 2012Publication date: December 26, 2013Applicant: DIREVO INDUSTRIAL BIOTECHNOLOGY GmbHInventors: Klaudija Milos, Claudia Stamme, Tanja Lindner, Vitaly Svetlichny, Andreas Scheidig
-
Publication number: 20130230886Abstract: Provided herein are antibodies, antigen binding portions, and derivatives thereof that are capable of binding tumor necrosis factor alpha (TNF?); nucleic acids encoding the antibodies, antigen binding portions, and derivatives thereof, including complementary nucleic acids; vectors; and host cells containing the nucleic acids.Type: ApplicationFiled: March 13, 2013Publication date: September 5, 2013Inventors: Christian Votsmeier, Uwe Gritzan, Kornelia Kirchner, Michael Strerath, Kerstin Baral, Ulrich Haupts, Wayne M. Coco, Susanne Steinig, Andreas Scheidig, Klaus Pellengahr, Simone Brückner, Hanna Plittersdorf, Peter Scholz, Jan Tebbe
-
Patent number: 8399627Abstract: Provided herein are antibodies, antigen binding portions, and derivatives thereof that are capable of binding tumor necrosis factor alpha (TNF?); nucleic acids encoding the antibodies, antigen binding portions, and derivatives thereof, including complementary nucleic acids; vectors; and host cells containing the nucleic acids.Type: GrantFiled: December 24, 2008Date of Patent: March 19, 2013Assignee: Bayer Pharma AGInventors: Christian Votsmeier, Uwe Gritzan, Kornelia Kirchner, Michael Strerath, Kerstin Baral, Ulrich Haupts, Wayne M. Coco, Susanne Steinig, Andreas Scheidig, Klaus Pellengahr, Simone Brückner, Hanna Plittersdorf, Peter Scholz, Jan Tebbe
-
Publication number: 20120237496Abstract: The present invention relates to polypeptides comprising protease variants of wild type human neprilysin having an altered specificity and/or activity. In particular the present invention relates to polypeptides comprising protease variants derived from human neprilysin having an increased specificity and/or activity against certain substrates, in particular against amyloid beta.Type: ApplicationFiled: June 21, 2010Publication date: September 20, 2012Inventors: Joerg Birkenfeld, Andrea Eicker, Per-Ola Freskgard, Claudia Gotzberger-Schad, Joanna Grudzinska, Ulrich Haupts, Josi Innig, Christoph Mahlert, Andreas Scheidig, Michael Strerath, Jan Tebbe, Johan Per-Wallin, Nina Wobst, Carl Innes Webster, Lutz Jermutus
-
Patent number: 7846705Abstract: The present invention provides an insertion, deletion and/or substitution mutein of wild-type Trichoderma reesei ?-mannanase having enhanced thermostability, proteolytic stability, specific activity and/or stability at low pH, a nucleic acid molecule encoding said mannanase mutein, a composition comprising said mannanase mutein; a method for its preparation, and its use for food and feed processing, for coffee extraction and the processing of coffee waste, as a supplement to food and feed, for enzyme aided bleaching of paper pulps, as bleaching and/or desizing agent in textile industry, for oil and gas well stimulation by hydraulic fracturing, as detergent, for removal of biofilms and in delivery systems, or for the processing of renewable resources intended for the production of biological fuels.Type: GrantFiled: July 17, 2007Date of Patent: December 7, 2010Assignee: Direvo Industrial Biotechnology GmbHInventors: Oliver Kensch, Wayne M. Coco, Andreas Scheidig, Ute Beister, Birgitta Leuthner, Nadine Koch, Markus Rarbach, Ulrich Kettling, Ulrich Haupts
-
Publication number: 20100297700Abstract: Provided herein are antibodies, antigen binding portions, and derivatives thereof that are capable of binding tumor necrosis factor alpha (TNF?); nucleic acids encoding the antibodies, antigen binding portions, and derivatives thereof, including complementary nucleic acids; vectors; and host cells containing the nucleic acids.Type: ApplicationFiled: December 24, 2008Publication date: November 25, 2010Inventors: Christian Votsmeier, Uwe Gritzan, Kornelia Kirchner, Michael Strerath, Kerstin Baral, Ulrich Haupts, Wayne Coco, Susanne Steinig, Andreas Scheidig, Klaus Pellengahr, Simone Brückner, Hanna Plittersdorf, Peter Scholz, Jan Tebbe
-
Publication number: 20090208440Abstract: The present invention provides engineered enzymes generated from protein scaffolds combined with Specificity Determining Regions, the production thereof and the use of said engineered enzymes for research, nutritional care, personal care and industrial purposes.Type: ApplicationFiled: January 4, 2008Publication date: August 20, 2009Inventors: Ulrich Haupts, Andre Koltermann, Andreas Scheidig, Christian Votsmeier, Ulrich Kettling, Oliver Kensch, Birgitta Leuthner
-
Publication number: 20090208474Abstract: The present invention provides engineered enzymes generated from protein scaffolds combined with Specificity Determining Regions, the production thereof and the use of said engineered enzymes for research, nutritional care, personal care and industrial purposes.Type: ApplicationFiled: December 21, 2007Publication date: August 20, 2009Inventors: Ulrich Haupts, Andre Koltermann, Andreas Scheidig, Christian Votsmeier, Ulrich Ketting
-
Publication number: 20080064064Abstract: The present invention provides an insertion, deletion and/or substitution mutein of wild-type Trichoderma reesei ?-mannanase having enhanced thermostability, proteolytic stability, specific activity and/or stability at low pH, a nucleic acid molecule encoding said mannanase mutein, a composition comprising said mannanase mutein; a method for its preparation, and its use for food and feed processing, for coffee extraction and the processing of coffee waste, as a supplement to food and feed, for enzyme aided bleaching of paper pulps, as bleaching and/or desizing agent in textile industry, for oil and gas well stimulation by hydraulic fracturing, as detergent, for removal of biofilms and in delivery systems, or for the processing of renewable resources intended for the production of biological fuels.Type: ApplicationFiled: July 17, 2007Publication date: March 13, 2008Applicant: DIREVO BIOTECH AGInventors: Oliver Kensch, Wayne Coco, Andreas Scheidig, Ute Beister, Birgitta Leuthner, Nadine Koch, Markus Rarbach, Ulrich Kettling, Ulrich Haupts
-
Patent number: 7335504Abstract: The present invention provides engineered enzymes generated from protein scaffolds combined with Specificity Determining Regions, the production thereof and the use of said engineered enzymes for research, nutritional care, personal care and industrial purposes.Type: GrantFiled: June 18, 2004Date of Patent: February 26, 2008Assignee: DIREVO Biotechnology AGInventors: Ulrich Haupts, Andre Koltermann, Andreas Scheidig, Christian Votsmeier, Ulrich Kettling